Clal Biotechnology Industries Ltd. (CBI.TA)
ILA 35.6
(-0.84%)
ILA 35.6
(-0.84%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -8.51 Million | -59.03 Million | -41.32 Million | -33.22 Million | 27.02 Million | -86.98 Million |
| Net Income | -28.09 Million | -95.43 Million | -128.21 Million | 49.83 Million | -326.21 Million | -28.86 Million |
| Depreciation & Amortization | 526 Thousand | 17.64 Million | 22.51 Million | 23.86 Million | 21.02 Million | 14.84 Million |
| Deferred income taxes | 14.85 Million | 31.12 Million | 56.1 Million | -107.98 Million | 310.85 Million | -239 Thousand |
| Stock-based compensation | 40 Thousand | 5.14 Million | 5.54 Million | 5.53 Million | 1.51 Million | -36.97 Million |
| Change in working capital | 1.2 Million | -20.32 Million | 2.16 Million | -1.75 Million | 11.69 Million | -9.46 Million |
| Other non-cash items | 2.95 Million | 2.8 Million | -167 Thousand | -2.25 Million | 8.16 Million | -26.28 Million |
| Investing Cash Flow | 7.65 Million | -10.95 Million | 79.18 Million | 70.78 Million | -23.52 Million | -118.23 Million |
| Investments in PPE | -5000.00 | -1.27 Million | -1.59 Million | -3.18 Million | -2.83 Million | -2.95 Million |
| Acquisitions | 3.15 Million | -12.69 Million | -13.42 Million | -1.11 Million | -2.73 Million | -52.13 Million |
| Investment purchases | -1.47 Million | -9.85 Million | -3.59 Million | -390 Thousand | -19.45 Million | -5.47 Million |
| Sales/Maturities of investments | 5.15 Million | 12.85 Million | 97.67 Million | 74.14 Million | 872 Thousand | 150 Thousand |
| Other Investing Activities | 825 Thousand | 15 Thousand | 118 Thousand | 1.32 Million | 618 Thousand | -57.82 Million |
| Financing Cash Flow | -1.18 Million | 20.05 Million | -51.54 Million | -2.38 Million | -2.51 Million | 78.98 Million |
| Debt repayment | -1.15 Million | -2.5 Million | -8.63 Million | -1.75 Million | -2.76 Million | - |
| Dividends payments | - | - | -36 Million | - | - | - |
| Common Stock Repurchased | - | - | -9.73 Million | -256 Thousand | - | - |
| Common Stock Issuance | 222 Thousand | 23.69 Million | 1.1 Million | 560 Thousand | - | 14.79 Million |
| Other Financing Activities | -25 Thousand | -3.64 Million | 1.73 Million | -2.68 Million | -2.51 Million | 64.19 Million |
| Accounts receivables | 1.01 Million | -6.6 Million | 2.01 Million | 3.15 Million | 10.09 Million | -4.42 Million |
| Accounts payables | - | 6.6 Million | -2.01 Million | -3.15 Million | -10.09 Million | - |
| Inventory | - | -2.25 Million | 582 Thousand | 733 Thousand | 347 Thousand | 539 Thousand |
| Other working capital | 190 Thousand | -18.07 Million | 1.58 Million | -2.49 Million | 11.34 Million | -10 Million |
| Cash at beginning of period | 7.44 Million | 53.04 Million | 68.15 Million | 37.55 Million | 40.36 Million | 164.24 Million |
| Cash at end of period | 5.72 Million | 7.44 Million | 53.04 Million | 68.15 Million | 37.55 Million | 40.36 Million |
| Capital Expenditure | -5000.00 | -1.27 Million | -1.59 Million | -3.18 Million | -2.83 Million | -2.95 Million |
| Effect of forex changes on cash | 324 Thousand | 4.33 Million | -1.42 Million | -4.57 Million | -3.8 Million | 2.34 Million |
| Net cash flow / Change in cash | -1.71 Million | -45.6 Million | -15.1 Million | 30.6 Million | -2.81 Million | -123.88 Million |
| Free Cash Flow | -8.51 Million | -60.31 Million | -42.92 Million | -36.41 Million | 24.19 Million | -89.93 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -16.73 Million | -28.09 Million | -16.73 Million | 1.21 Million | 1.21 Million | -95.43 Million |
| Depreciation & Amortization | 132.5 Thousand | 526 Thousand | 132.5 Thousand | 130.5 Thousand | 130.5 Thousand | 17.64 Million |
| Deferred income taxes | - | 14.85 Million | - | - | - | 31.12 Million |
| Stock-based compensation | -107.5 Thousand | 40 Thousand | -107.5 Thousand | 127.5 Thousand | 127.5 Thousand | 5.14 Million |
| Change in working capital | -200 Thousand | 1.2 Million | -200 Thousand | 802.5 Thousand | 802.5 Thousand | -20.32 Million |
| Other non-cash items | 14.48 Million | 2.95 Million | 14.48 Million | -4.09 Million | -4.09 Million | 2.8 Million |
| Investing Cash Flow | 102 Thousand | 7.65 Million | 102 Thousand | 3.72 Million | 3.72 Million | -10.95 Million |
| Investments in PPE | - | -5000.00 | - | -2500.00 | -2500.00 | -1.27 Million |
| Acquisitions | - | 3.15 Million | - | - | - | -12.69 Million |
| Investment purchases | - | -1.47 Million | - | - | - | -9.85 Million |
| Sales/Maturities of investments | - | 5.15 Million | - | - | - | 12.85 Million |
| Other Investing Activities | 102 Thousand | 825 Thousand | 102 Thousand | 3.72 Million | 3.72 Million | 15 Thousand |
| Financing Cash Flow | -81 Thousand | -1.18 Million | -81 Thousand | -509 Thousand | -509 Thousand | 20.05 Million |
| Debt repayment | - | -1.15 Million | - | - | - | -2.5 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 222 Thousand | - | - | - | 23.69 Million |
| Other Financing Activities | -81 Thousand | -25 Thousand | -81 Thousand | -509 Thousand | -509 Thousand | -3.64 Million |
| Accounts receivables | 105.5 Thousand | 1.01 Million | 105.5 Thousand | 402 Thousand | 402 Thousand | -6.6 Million |
| Accounts payables | - | - | - | - | - | 6.6 Million |
| Inventory | - | - | - | - | - | -2.25 Million |
| Other working capital | -305.5 Thousand | 190 Thousand | -305.5 Thousand | 400.5 Thousand | 400.5 Thousand | -18.07 Million |
| Cash at beginning of period | - | 7.44 Million | - | - | 7.44 Million | 53.04 Million |
| Cash at end of period | -2.39 Million | 5.72 Million | -2.39 Million | 1.53 Million | 8.98 Million | 7.44 Million |
| Capital Expenditure | - | -5000.00 | - | -2500.00 | -2500.00 | -1.27 Million |
| Effect of forex changes on cash | 15 Thousand | 324 Thousand | 15 Thousand | 147 Thousand | 147 Thousand | 4.33 Million |
| Net cash flow / Change in cash | -2.39 Million | -1.71 Million | -2.39 Million | 1.53 Million | 1.53 Million | -45.6 Million |
| Free Cash Flow | -2.43 Million | -8.51 Million | -2.43 Million | -1.82 Million | -1.82 Million | -60.31 Million |
000937
NNBR
FBK
SPYR
MWY
WTER